Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.68 USD
-0.49 (-0.74%)
Updated May 24, 2024 03:59 PM ET
After-Market: $65.47 -0.21 (-0.32%) 7:58 PM ET
5-Strong Sell of 5 5
B Value C Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $1.59 | -1.29% |
Earnings Summary
For their last quarter, Gilead Sciences (GILD) reported earnings of -$1.32 per share, beating the Zacks Consensus Estimate of $-1.49 per share. This reflects a positive earnings surprise of 11.41%. Look out for GILD's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $1.59 per share, reflecting a year-over-year increase of 18.66%.
Earnings History
Price & Consensus
Zacks News for GILD
Gilead (GILD) Announces Positive Interim Results on PBC Drug
GILD: What are Zacks experts saying now?
Zacks Private Portfolio Services